CA-IB cuts Hungary Egis, Richter target prices over local, Russian changes
CA-IB has reduced its target price on Hungarian pharmaceutical companies Egis and Richter to Ft 31,473 from Ft 36,540 and to Ft 45,298, respectively, following a revision of its model over unfavorable changes to come in Hungary's drug subsidy regime and Russia DLO program.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.